Skip to main content
Top
Published in: Clinical Rheumatology 10/2021

01-10-2021 | SARS-CoV-2 | Original Article

Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children

Authors: Fatih Haslak, Kenan Barut, Cansu Durak, Ayten Aliyeva, Mehmet Yildiz, Vafa Guliyeva, Sevki Erdem Varol, Sinem Oral Cebeci, Fatih Aygun, Yusuf Ziya Varli, Abdulrahman Ozel, Sertac Hanedan Onan, Ulkem Kocoglu, Meltem Erol, Fatih Karagozlu, Nujin Ulug, Reyhan Dedeoglu, Sezgin Sahin, Amra Adrovic, Funda Oztunc, Ozgur Kasapcopur

Published in: Clinical Rheumatology | Issue 10/2021

Login to get access

Abstract

Objectives

Multi-system inflammatory syndrome in children (MIS-C) is a less understood and a rare complication of coronavirus disease-2019 (COVID-19). Given the scarce data regarding this novel disease, we aimed to describe the clinical features and outcomes of our patients with MIS-C and to evaluate the associated factors for the pediatric intensive care unit (PICU) admission.

Methods

The MIS-C patients under 18 years old diagnosed and treated in three referral centers between July 2020 and March 2021 were included. Data of the patients were retrospectively obtained from their medical records.

Results

Overall, 76 subjects (24 females) with a mean age of 8.17 ± 4.42 years were enrolled. Twenty-seven (35.5%) patients were admitted to the PICUs. The two most common systemic involvement patterns were cardiac and gastrointestinal. There was only one lethal outcome in a patient with underlying acute lymphoblastic leukemia. Those with higher procalcitonin levels at admission were found to stay longer in the hospital (r = 0.254, p = 0.027). The risk of PICU admission increased with age (aOR: 1.277; 95% CI: 1.089–1.498; p = 0.003) and with decreased initial serum albumin levels (aOR: 0.105; 95% CI: 0.029–0.378; p = 0.001).

Conclusion

Although there is a wide clinical variability among the patients with MIS-C, we suggest that those with older age and lower initial serum albumin levels merit close monitoring due to their higher risk for PICU admission.
Key Points
Although there is a wide variability regarding the management process among clinicians, MIS-C is a rare, severe, less understood complication of COVID-19 that may cause rapid clinical deterioration in the patients.
Clinicians should be aware of this condition in children with persistent fever and a family history of COVID-19.
Older age and low serum albumin levels are the independent predictors for the pediatric intensive care unit admission among MIS-C patients.
 
Literature
1.
go back to reference Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506CrossRef Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506CrossRef
2.
go back to reference Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J et al (2020) SARS-CoV-2 infection in children. N Engl J Med 382(17):1663–1665CrossRef Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J et al (2020) SARS-CoV-2 infection in children. N Engl J Med 382(17):1663–1665CrossRef
3.
go back to reference Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395(10237):1607–1608CrossRef Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395(10237):1607–1608CrossRef
4.
go back to reference Haslak F, Yildiz M, Adrovic A, Sahin S, Koker O, Aliyeva A et al (2020) Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic. Rheumatol Int 40(9):1423–1431CrossRef Haslak F, Yildiz M, Adrovic A, Sahin S, Koker O, Aliyeva A et al (2020) Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic. Rheumatol Int 40(9):1423–1431CrossRef
6.
go back to reference Schvartz A, Belot A, Kone-Paut I (2020) Pediatric inflammatory multisystem syndrome and rheumatic diseases during SARS-CoV-2 pandemic. Front Pediatr 8:605807CrossRef Schvartz A, Belot A, Kone-Paut I (2020) Pediatric inflammatory multisystem syndrome and rheumatic diseases during SARS-CoV-2 pandemic. Front Pediatr 8:605807CrossRef
7.
go back to reference Bhat CS, Gupta L, Balasubramanian S, Singh S, Ramanan AV (2020) Hyperinflammatory syndrome in children associated with COVID-19: need for awareness. Indian Pediatr 57(10):929–935CrossRef Bhat CS, Gupta L, Balasubramanian S, Singh S, Ramanan AV (2020) Hyperinflammatory syndrome in children associated with COVID-19: need for awareness. Indian Pediatr 57(10):929–935CrossRef
8.
go back to reference Haslak F, Yıldız M, Adrovic A, Şahin S, Barut K, Kasapçopur Ö (2021) A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C). Turk Arch Pediatr 56:3–9PubMedPubMedCentral Haslak F, Yıldız M, Adrovic A, Şahin S, Barut K, Kasapçopur Ö (2021) A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C). Turk Arch Pediatr 56:3–9PubMedPubMedCentral
9.
go back to reference García-Salido A, de Carlos Vicente JC, Belda Hofheinz S, Balcells Ramírez J, Slöcker Barrio M, Leóz Gordillo I et al (2020) Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care 24(1):666CrossRef García-Salido A, de Carlos Vicente JC, Belda Hofheinz S, Balcells Ramírez J, Slöcker Barrio M, Leóz Gordillo I et al (2020) Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care 24(1):666CrossRef
10.
go back to reference Prata-Barbosa A, Lima-Setta F, Santos GRD, Lanziotti VS, de Castro REV, de Souza DC et al (2020) Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study. J Pediatr (Rio J) 96(5):582–592CrossRef Prata-Barbosa A, Lima-Setta F, Santos GRD, Lanziotti VS, de Castro REV, de Souza DC et al (2020) Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study. J Pediatr (Rio J) 96(5):582–592CrossRef
11.
go back to reference Shobhavat L, Solomon R, Rao S, Bhagat I, Prabhu S, Prabhu S et al (2020) Multisystem inflammatory syndrome in children: clinical features and management-intensive care experience from a pediatric public hospital in Western India. Indian J Crit Care Med 24(11):1089–1094CrossRef Shobhavat L, Solomon R, Rao S, Bhagat I, Prabhu S, Prabhu S et al (2020) Multisystem inflammatory syndrome in children: clinical features and management-intensive care experience from a pediatric public hospital in Western India. Indian J Crit Care Med 24(11):1089–1094CrossRef
13.
go back to reference McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927–e999CrossRef McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927–e999CrossRef
14.
go back to reference McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116(2):174–179CrossRef McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116(2):174–179CrossRef
15.
go back to reference Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H et al (2020) American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol 72(11):1791–1805CrossRef Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H et al (2020) American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol 72(11):1791–1805CrossRef
16.
go back to reference Tang Y, Li W, Baskota M, Zhou Q, Fu Z, Luo Z et al (2021) Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies. Transl Pediatr 10(1):121–135CrossRef Tang Y, Li W, Baskota M, Zhou Q, Fu Z, Luo Z et al (2021) Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies. Transl Pediatr 10(1):121–135CrossRef
17.
go back to reference Alharbi M, Kazzaz YM, Hameed T, Alqanatish J, Alkhalaf H, Alsadoon A et al (2021) SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health 14(4):446–453CrossRef Alharbi M, Kazzaz YM, Hameed T, Alqanatish J, Alkhalaf H, Alsadoon A et al (2021) SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health 14(4):446–453CrossRef
19.
go back to reference Başar EZ, Sönmez HE, Öncel S, Yetimakman AE, Babaoğlu A (2021) Multisystemic inflammatory syndrome in children associated with COVID-19: a single center experience in Turkey. Turk Arch Pediatr 56(3):192–199CrossRef Başar EZ, Sönmez HE, Öncel S, Yetimakman AE, Babaoğlu A (2021) Multisystemic inflammatory syndrome in children associated with COVID-19: a single center experience in Turkey. Turk Arch Pediatr 56(3):192–199CrossRef
20.
go back to reference Riollano-Cruz M, Akkoyun E, Briceno-Brito E, Kowalsky S, Reed J, Posada R et al (2021) Multisystem inflammatory syndrome in children related to COVID-19: a New York City experience. J Med Virol 93(1):424–433CrossRef Riollano-Cruz M, Akkoyun E, Briceno-Brito E, Kowalsky S, Reed J, Posada R et al (2021) Multisystem inflammatory syndrome in children related to COVID-19: a New York City experience. J Med Virol 93(1):424–433CrossRef
21.
go back to reference Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R et al (2020) Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York City. J Pediatr 224:24–29CrossRef Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R et al (2020) Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York City. J Pediatr 224:24–29CrossRef
22.
go back to reference Mukherjee S, Pahan K (2021) Is COVID-19 Gender-sensitive? J Neuroimmune Pharmacol 16(1):38–47CrossRef Mukherjee S, Pahan K (2021) Is COVID-19 Gender-sensitive? J Neuroimmune Pharmacol 16(1):38–47CrossRef
23.
go back to reference Wood LE, Tulloh RM (2009) Kawasaki disease in children. Heart 95(10):787–792CrossRef Wood LE, Tulloh RM (2009) Kawasaki disease in children. Heart 95(10):787–792CrossRef
24.
go back to reference Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al (2020) Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 324(3):259–269CrossRef Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al (2020) Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 324(3):259–269CrossRef
25.
go back to reference Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395(10239):1771–1778CrossRef Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395(10239):1771–1778CrossRef
26.
go back to reference Lin MT, Wu MH (2017) The global epidemiology of Kawasaki disease: review and future perspectives. Glob Cardiol Sci Pract 2017(3):e201720PubMedPubMedCentral Lin MT, Wu MH (2017) The global epidemiology of Kawasaki disease: review and future perspectives. Glob Cardiol Sci Pract 2017(3):e201720PubMedPubMedCentral
27.
go back to reference Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al (2020) Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation 142(5):429–436CrossRef Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al (2020) Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation 142(5):429–436CrossRef
28.
go back to reference Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C et al (2020) Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: A Case Series. J Pediatric Infect Dis Soc 9(3):393–398CrossRef Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C et al (2020) Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: A Case Series. J Pediatric Infect Dis Soc 9(3):393–398CrossRef
29.
go back to reference Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J et al (2020) COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep 69(32):1074–1080CrossRef Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J et al (2020) COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep 69(32):1074–1080CrossRef
30.
go back to reference Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP et al (2021) Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health 5(5):323–331CrossRef Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP et al (2021) Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health 5(5):323–331CrossRef
31.
go back to reference Netea MG, Giamarellos-Bourboulis EJ, Domínguez-Andrés J, Curtis N, van Crevel R, van de Veerdonk FL et al (2020) Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell 181(5):969–977CrossRef Netea MG, Giamarellos-Bourboulis EJ, Domínguez-Andrés J, Curtis N, van Crevel R, van de Veerdonk FL et al (2020) Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell 181(5):969–977CrossRef
32.
go back to reference Pavel AB, Wu J, Renert-Yuval Y, Del Duca E, Glickman JW, Miller RL et al (2021) SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age. Allergy 76(3):875–878CrossRef Pavel AB, Wu J, Renert-Yuval Y, Del Duca E, Glickman JW, Miller RL et al (2021) SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age. Allergy 76(3):875–878CrossRef
33.
go back to reference Lingappan K, Karmouty-Quintana H, Davies J, Akkanti B, Harting MT (2020) Understanding the age divide in COVID-19: why are children overwhelmingly spared? Am J Physiol Lung Cell Mol Physiol 319(1):L39-l44CrossRef Lingappan K, Karmouty-Quintana H, Davies J, Akkanti B, Harting MT (2020) Understanding the age divide in COVID-19: why are children overwhelmingly spared? Am J Physiol Lung Cell Mol Physiol 319(1):L39-l44CrossRef
34.
go back to reference Zhao Y, Yin L, Patel J, Tang L, Huang Y (2021) The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis. J Med Virol 93(7):4358–4369. https://doi.org/10.1002/jmv.26951 Zhao Y, Yin L, Patel J, Tang L, Huang Y (2021) The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis. J Med Virol 93(7):4358–4369. https://​doi.​org/​10.​1002/​jmv.​26951
Metadata
Title
Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children
Authors
Fatih Haslak
Kenan Barut
Cansu Durak
Ayten Aliyeva
Mehmet Yildiz
Vafa Guliyeva
Sevki Erdem Varol
Sinem Oral Cebeci
Fatih Aygun
Yusuf Ziya Varli
Abdulrahman Ozel
Sertac Hanedan Onan
Ulkem Kocoglu
Meltem Erol
Fatih Karagozlu
Nujin Ulug
Reyhan Dedeoglu
Sezgin Sahin
Amra Adrovic
Funda Oztunc
Ozgur Kasapcopur
Publication date
01-10-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 10/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-05780-x

Other articles of this Issue 10/2021

Clinical Rheumatology 10/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.